Lupin Atlantis Holdings v. Mylan Inc.

U.S. Court of Appeals for the Federal Circuit

Lupin Atlantis Holdings v. Mylan Inc.

Opinion

United States Court of Appeals for the Federal Circuit ______________________

IN RE FENOFIBRATE PATENT LITIGATION ______________________

LUPIN ATLANTIS HOLDINGS S.A., Plaintiff-Appellant,

v.

MYLAN INC. AND MYLAN PHARMACEUTICALS INC., Defendants-Appellees,

AND

ETHYPHARM, S.A., Defendant.

______________________

2013-1141 ______________________

Appeal from the United States District Court for the Southern District of New York in Nos. 11-MD-2241, 11- CV-3861, and 11-CV-3893, Judge Jed S. Rakoff. ______________________

JUDGMENT ______________________ ROBERT F. GREEN, Leydig, Voit & Mayer, Ltd, of Chi- cago, Illinois, argued for plaintiff-appellant. With him on the brief were CHRISTOPHER T. GRIFFITH and KATE M. LESCIOTTO; and JAMAICA P. SZELIGA, of Washington, DC. Of counsel was JESSICA M. TYRUS.

JAMES H. WALLACE, JR., Wiley Rein LLP, of Washing- ton, DC, argued for defedants-appellees. With him on the brief were MARK A. PACELLA, ROBERT J. SCHEFFEL, CLAIRE J. EVANS, KARIN A. HESSLER, and ADRIENNE G. JOHNSON. ______________________

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

PER CURIAM (PROST, MOORE, and O'MALLEY, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

February 28, 2013 /s/ Jan Horbaly Date Jan Horbaly Clerk

Reference

Status
Unpublished